DEPOMED, INC. v. ZYDUS PHARMACEUTICALS (USA), INC.
3:12-cv-02813
Overview
Parties
Defendant
ZYDUS PHARMACEUTICALS (USA), INC. Operating Company
Represented By
2 Attorneys ListedHILL WALLACK, LLP
202 CARNEGIE CENTER, PRINCETON, NJ 08543
CADILA HEALTHCARE LIMITED NPE (University / Research)
Represented By
2 Attorneys ListedHILL WALLACK, LLP
202 CARNEGIE CENTER, PRINCETON, NJ 08543
DEPOMED, INC. Operating Company
Represented By
2 Attorneys ListedROBINSON, WETTRE & MILLER LLC
ROBINSON, WETTRE & MILLER LLC, ONE NEWARK CENTER
ROBINSON WETTRE & MILLER LLC
ROBINSON WETTRE & MILLER LLC, ONE NEWARK CENTER
Court & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
Endo Pharmaceutical Inc. et al. v. Depomed, Inc.
Endo Pharmaceutical Inc. et al. v. Depomed, Inc.
Purdue Pharma L.P. v. DepoMed, Inc.
Depomed Inc. v. Watson Laboratories Inc. - Florida
Patents Involved
There are 8 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8333992
Gastric retained gabapentin dosage form
|
Filed: 2012-07-27
Issued: 2012-12-18
|
Active (5.7 yrs remaining)
Expires: 2032-07-27
|
|
|
US6340475
Extending the duration of drug release within the stomach during the fed mode
|
Filed: 1999-03-29
Issued: 2002-01-22
|
Expired (Term Ended)
Expires: 2019-03-29
|
|
|
US6488962
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
Filed: 2000-06-20
Issued: 2002-12-03
|
Expired (Term Ended)
Expires: 2020-06-20
|
|
|
US6635280
Extending the duration of drug release within the stomach during the fed mode
|
Filed: 2001-11-06
Issued: 2003-10-21
|
Expired (Term Ended)
Expires: 2021-11-06
|
|
|
US7438927
Methods of treatment using a gastric retained gabapentin dosage
|
Filed: 2003-01-22
Issued: 2008-10-21
|
Expired (Term Ended)
+400d PTA
Expires: 2024-02-26
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
15
Dispositive
0
Granted
6
Denied
0
Pending / Review
9
Motions by Category
Key Dispositive Motions & Rulings